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Abstract
The elevated level of circulating estradiol increases the risk of breast tumor development. To gain further insight into mechanisms involved in
their actions, we investigated the molecular mechanisms of 4-hydroxyestradiol (4-OHE2) to initiate and/or promote abnormal cell growth, and of 
α- or γ-tocopherol to inhibit this process. MCF-10A, human breast epithelial cells were incubated with 0.1 μM 4-OHE2, either with or without
30  μM tocopherols for 96 h. 4-OHE2  caused the accumulation of intracellular ROS, while cellular GSH/GSSG ratio and MnSOD protein levels 
were decreased, indicating that there was an oxidative burden. 4-OHE2 treatment also changed the levels of DNA repair proteins, BRCA1 and PARP-1.
γ-Tocopherol suppressed the 4-OHE2-induced increases in ROS, GSH/GSSG ratio, and MnSOD protein expression, while α-tocopherol up-regulated 
BRCA1 and PARP-1 protein expression. In conclusion, 4-OHE2 increases oxidative stress reducing the level of proteins related to DNA repair.
Tocopherols suppressed oxidative stress by scavenging ROS or up-regulating DNA repair elements.
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Introduction
The etiology of breast cancer is related to multiple factors, 
a significant one of which is estrogen exposure (Colditz, 1998; 
Grodstein  et al., 1997; Service, 1998). 4-Hydroxyestradiol 
(4-OHE2) is hydroxylated metabolite of 17β-estradiol formed by 
CYP1B1. This catechol estradiol is further oxidized by sequential 
one-electron oxidations to produce the estrogen semiquinone 
radical and estrogen quinone. In rodent models, estrogens have 
been shown to act as carcinogens through a mechanism that 
involves oxidative stress in various tissues including kidney, 
liver, and breast (Han & Liehr, 1994; Harvell et al., 2000; Yager 
& Liehr, 1996).
Several cellular defense molecules including superoxide 
dismutase (SOD) and reduced glutathione (GSH) protect cells 
from oxidative damage. Manganese superoxide dismutase 
(MnSOD) catalyzes the conversion of superoxide to hydrogen 
peroxide in mitochondria. It has been demonstrated that MnSOD 
levels are lowered in certain cancer cells (Hitchler et al., 2006), 
while other studies have shown that the stimulated expression 
of MnSOD suppresses malignant phenotypes in mammalian 
tumor cells, including breast (Li et al., 1998), prostate (Liu et 
al., 1997), and oral carcinoma cells (Liu et al., 1998). The 
GSH/GSSG ratio is tightly regulated under normal circumstances, 
while the balance shifts towards a low GSH/GSSG ratio under 
conditions of oxidative stress. The ratio of GSH/GSSG measured 
in the blood of patients with colon and breast cancer has been 
found to be significantly decreased compared to that of control 
subjects (Pastore et al., 2003).
Several proteins are involved in oxidative DNA damage repair, 
and therefore genetic defects in these proteins increase the risk 
of developing breast cancer. Breast cancer susceptibility gene 1 
(BRCA1), for example, regulates cell cycle progression and DNA 
damage repair, and maintains genomic integrity (Rosen et al., 
2003). In addition, BRCA1 stimulates antioxidant response 
element-driven transcriptional activity and shifts the cellular 
redox balance to a higher ratio of reduced to oxidized glutathione 
(Bae et al., 2004). Inherited mutations or deficiencies in BRCA1 
predispose its carriers to higher risks
  of breast and ovarian 
cancers (King et al., 2003; Walsh et al., 2007). Poly (ADP-ribose) 
polymerase-1 (PARP-1), a nuclear member of the PARP 
superfamily, binds rapidly to DNA single and double strand 186 Tocopherols suppress adverse effects of 4-hydroxyestradiol
breaks where its activation facilitates DNA repair (Ame et al., 
2004).
  In addition, PARP-1 is essential for the regulation of 
BRCA1 in response to DNA damage (Tong et al., 2007). PARP-1 
complementation partly rescues defective DNA damage response 
resulting from defective BRCA1. Hence, BRCA1 and PARP-1 
are thought to respond to cellular oxidative stress including 
exposure to the oxidized estradiol metabolites.
Cancer patients have been shown to have low concentrations 
of tissue and plasma tocopherols compared to their healthy 
counterparts (Abiaka et al., 2001; Goodman et al., 2003; 
McMillan  et al., 2002). The functions of tocopherols in 
scavenging lipid peroxyl radicals in biological membranes are 
well documented (Baba et al., 2005). A recent report has 
demonstrated that tocopherols can also directly suppress ROS 
production by interfering with the assembly of membrane-bound 
NADPH-oxidase complexes (Wittmann et al., 2005). Tocopherols 
also regulate the expression of genes related to cell proliferation, 
cell cycle progression, and apoptosis in an antioxidant- 
independent way (Campbell et al., 2003; Campbell et al., 2006; 
Gysin  et al., 2002; Roy et al., 2002).
In this study, we hypothesized that continuous exposure of 
normal breast epithelial cells to 4-OHE2  increases oxidative stress 
and disrupts redox balance thereby altering the availability of 
repair elements. Effects of α- or γ-tocopherol on the markers 




All chemicals were purchased from Sigma-Aldrich (St. Louis, 
MO, USA) unless stated otherwise. Cholera toxin was obtained 
from List Laboratories (Campbell, CA, USA). Culture media, 
epidermal growth factor, penicillin-streptomycin, horse serum 
and glutamine were purchased from Invitrogen (Carlsbad, CA, 
USA). Anti-MnSOD, BRCA1, and HRP-conjugated secondary 
antibody were obtained from Upstate (Lake Placid, NY, USA). 
The glutathione assay kit was obtained from Cayman Chemical 
(Ann Arbor, MI, USA). PRO-PREP
TM was purchased from 
iNtRON Biotechnology (Daejeon, Korea). The Bradford protein 
assay kit was purchased from BioRad laboratories (Hercules, CA, 
USA).
Cell culture
Human mammary epithelial cells (MCF-10A) obtained from 
ATCC (Manassas, VA, USA) were cultured in DMEM/F12 
containing 10 μg/ml bovine insulin, 100 ng/ml cholera toxin, 0.5 
μg/ml hydrocortisone, 20 ng/ml recombinant human epidermal 
growth factor, 2 mM L-glutamine, 100 μg/ml penicillin/streptomycin, 
and 5% horse serum at 37℃ in an atmosphere of 5% CO2. The 
non-tumorigenic MCF-10A cell line was originally derived from 
a patient with proliferative breast disease (Cuendet & Bolton, 
2006).
Cell treatment
MCF-10A cells were incubated with 0.1 μM 4-OHE2, either 
with or without 30 μM tocopherol for 24 to 96 h. 4-OHE2 and 
tocopherols were replaced every day during the incubation 
period.
Measurement of intracellular ROS accumulation
MCF-10A cells were washed and treated for 20 min with 100 
μM 2’, 7’-dichlorodihydrofluorescein diacetate (DCFH-DA), a 
nonfluoroscent probe that diffuses into cells. Cytoplasmic 
esterase hydrolyzes DCFH-DA to 2’, 7’-dichlorodihydrofluorescein 
(DCFH) and then ROS generated within cells oxidize DCFH to 
the fluorescent dye, 2’, 7’-dichlorofluorescein (DCF). The intensity 
of DCF was measured by a flow cytometry (FACS Calibur, 
Becton Dickinson, USA) at 530 nm using an FL1 filter. 
Measurement of GSH/GSSG ratios
MCF-10A cells were collected by centrifugation at 1000×g for 
5 min at 4℃. The cell pellet was sonicated in 1 mL PBS (pH 
7.2) and centrifuged at 13,000×g for 20 min. Total GSH and 
GSSG were measured using a glutathione assay kit. The GSH 
disulfide (GSSG) content of cells was determined by adding 10 
μL 2-vinylpyridine solution per mL of sample in order to remove 
GSH according to the method described by Griffith (1980).
Protein extraction and western blot analysis
Cells were harvested by trypsinization, washed with PBS (pH 
7.2) and the pellets were collected. The pellets were extracted 
using the PRO-PREP
TM and protein concentration was determined. 
Protein (30 μg) was added to each well of 10-12% SDS-PAGE. 
The gel was run at 100 V, 250 mA and transferred to a PVDF 
membrane (Amersham Pharmacia Biotech, Piscataway, NJ, USA) 
for 80 min. The membrane was blocked in blocking buffer (0.2% 
Tween 20 in PBS, pH 7.2), containing 5% non-fat dry milk for 
2 h at room temperature. Dilution of primary antibodies (MnSOD 
1:2000, BRCA1 1:250, PARP-1 1:500) was made in blocking 
buffer. The blots were incubated with primary antibody for 2 
h at room temperature. Following three washes with 0.2% Tween 
20 in PBS, pH 7.2 (PBST), the blots were incubated with 
horseradish peroxidase-conjugated secondary antibodies in 
blocking buffer for 1 h at room temperature. The blots were then 
washed three times with PBST, and developed with ECL 
(Amersham Pharmacia Biotech, Piscataway, NJ, USA) for 1 min. 
Band intensity was measured by Versa Doc 5000 (Bio Rad, 
Hercules, CA, USA).Eun-Ju Lee et al. 187
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Fig. 1. Effect of 4-hydroxyestradiol (4-OHE2) on oxidative markers in MCF-10A cells. A. Effect of 4-hydroxyestradiol (4-OHE2) on intracellular ROS levels in MCF-10A 
cells. MCF-10A cells were treated with or without 0.1 μM 4-OHE2 for 24 h to 96 h. The ROS accumulation was measured using DCF-DA as described in materials and 
methods. * Significantly different from the control value (P < 0.05). B. Effect of 4-hydroxyestradiol (4-OHE2) on GSH levels in MCF-10A cells. MCF-10A cells were incubated 
with or without 0.1 μM 4-OHE2 for 24 to 96 h. The level of GSH was m easured as described in materials and methods. *Significantly different from the control value (P
< 0.05). C. Effect of 4-hydroxyestradiol (4-OHE2) on M nSOD  p rotein exp ression in M CF-10A cells. M CF-10A cells were incubated with or without 0.1 μM 4-OHE2 for 24 
to 96 h. MnSOD protein expression was detected by western blot analysis and normalized by β-actin as described in materials and methods. ** Significantly different from 
the  control  value  (P < 0.01).  Values  present  means  ±  standard  deviation  (n=3  or  4).
(A) (B)
Fig. 2. Effect of 4-hydroxyestradiol (4-OHE2) on BRCA1 and PARP-1 protein expression in MCF-10A cells. A. Effect of 4-hydroxyestradiol (4-OHE2) on BRCA1 protein 
expression in MCF-10A cells. MCF-10A cells were incubated with or without 0.1 μM 4-OHE 2 for 24 to 96 h. BRCA1 protein expression was detected by western blot as 
described in materials and methods. * Significantly different from the control value (P < 0.05). B. Effect of 4-hydroxyestradiol (4-OHE2) on PARP-1 protein in MCF-10A cells. 
MCF-10A cells were incubated with or without 0.1 μM 4-OHE2 for 24 to 96 h. PARP-1 protein was detected by western blot analysis and normalized by β-actin as described
in  materials  and  methods.  *  Significantly  different  from  the  control  value,  P < 0.05.Values  present  means  ± standard  deviation  (n=3  or  4).
Statistical analysis
Data were expressed as the mean ± SD. Differences in 4-OHE2 
treated and non-treated group were analyzed by Student’s t-test. 
Comparisons among the treatments were tested by ANOVA 
followed Duncan’s multiple range test. All statistical tests were 
performed using the SAS statistical package Version 9.0 (SAS 
Institute, Cary, NC).
Results
Changes in oxidative stress markers 
Following the exposure of cells to 0.1 μM 4-OHE2  for 96 h, 
intracellular ROS was increased by 60% (Fig. 1A). Cellular 
GSH/GSSG ratios were increased at 24 h and then decreased 
at 48 and 96 h (Fig. 1B). The expression of MnSOD, a key 
antioxidant enzyme involved in scavenging oxygen radicals was 
significantly decreased at 72 h and 96 h (Fig. 1C).
Changes in oxidative stress-related DNA damage response 
proteins 
DNA damage response elements including BRCA1 and 
PARP-1 are closely related to the regulation of oxidative stress 
in breast cancer. As shown in Fig. 2A, BRCA1 protein levels 
were significantly suppressed at 48 h, while longer exposure (72 
h) to 4-OHE2  restored the level. Fig. 2B shows a significant 
decrease in PARP-1 level at 48 h when cells were treated with 




Fig. 3. Effect of α- and γ-tocopherol on oxidative stresses in MCF-10A cells. 
A. Effect of α-and γ-tocopherols on 4-OHE2 induced ROS in MCF-10A. MCF-10A 
cells were incubated with or without 0.1 μM 4-OHE2 only with or without 30 μM 
α -, or γ -tocop herols for 96 h. Different sup erscrip ts (a, b, c) indicate significant 
differences (P < 0.05). B.  Effect of α- and γ-tocopherol on GSH/GSSG levels in 
MCF-10A cells. MCF-10A cells were incubated with or without 0.1 μM 4-OHE2 only 
with or without 30 μM α-, or γ-tocopherols for 96 h. * Significantly different from 
4-OHE2 value, P < 0.05. Different superscripts (a, b) indicate significant differences 
(P < 0.05). C.  Effect of α- and γ-tocopherol on MnSOD expression in MCF-10A 
cells. MCF-10A cells were incubated with or without 0.1 μM 4-OHE2 with or without 
30 μM α-, or γ-tocopherols for 96 h. MnSOD protein expression was detected 
by western blot analysis and normalized by β-actin as described in materials and 
methods.  Different  superscripts  (a,  b,  c) indicate  significant  differences (P < 0.05). 
Values  present  means  ±  standard  deviation  (n=3  or  4).
Fig. 4. Effect of α- and γ-tocopherol on BRCA 1 and PARP-1 expression in 
MCF-10A cells. MCF-10A cells were incubated with or without 0.1 μM 4-OHE2
with or without 30μM α-, or γ-tocopherols for 48 h. BRCA1 and PARP-1 protein 
expression was detected by western blot analysis and normalized b y β -actin  as 
d e s c r i b e d  i n  m a t e r i a l s  a n d  m e t h o d s .  D i f f e r e n t  s u p e r s c r i p t s  ( a ,  b,  c)  indicate 
significant differences (P < 0.05). Values present means ± standard deviation (n=3 
or  4).
at 72 h exposure. 
Effects of tocopherols on modulating oxidative stress
Cells treated with 30 μM  γ-tocopherol showed a decreased 
level of intracellular ROS (Fig. 3A). γ-Tocopherol increased the 
GSH/GSSG ratio by reducing the level of GSSG (Fig. 3B). 
MnSOD protein level was increased with γ-tocopherol treatment 
(Fig. 3C). Although α-tocopherol did not exert a significant effect 
on these markers, it inhibited 4-OHE2-induced BRCA1 and 
PARP-1 depletion (Fig. 4A, 4B).
Discussion
Carcinogenesis can be viewed as a stepwise process beginning 
with genotoxic events followed by enhanced cell proliferation 
and tumor progression. Evidence has accumulated supporting the 
theory that catechol estrogens are oxidized to quinones 
accompanied by the generation of ROS, capable of causing 
genotoxicity and tumorigenicity. Despite the importance of this 
process, a limited number of studies have attempted to evaluate 
oxidized estrogen as a possible compound affecting redox 
balance in the cellular environment and the possible effects of 
antioxidant intervention. Therefore, we investigated the molecular 
events involved in 4-hydroxyestradiol (4-OHE2)-induced oxidative 
stresses as a possible events in cancer initiation process using 
normal breast epithelial cells. Protective roles of tocopherols were 
also determined.
In the present study, ROS levels, GSH/GSSG ratios, and 
manganese superoxide dismutase (MnSOD) protein levels were 
measured as indicators of oxidative stress in normal breast 
epithelial cells treated with 0.1 μM 4-OHE2, which is close to 
the physiological concentration in breast tissue. Changes in ROS 
level and the GSSG/GSH ratio indicate that intracellular ROS 
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In addition, reactive quinone formed from 4-OHE2 can produce 
a conjugate with GSH causing depletion of cellular thiol levels, 
which renders the cells vulnerable to oxidative damage. Since 
H2O2-detoxifying enzymes were poorly expressed in breast 
cancer cells (Esworthy et al., 1995),
  ROS accumulation may exert 
a greater effect in breast tumor development. We observed the 
restoration of GSH/GSSG balance in cells treated for 72 h. 
Cellular exposure to xenobiotics also results in a temporal 
increase in the total intracellular GSH content (Arrigo, 1999) 
indicating that cellular redox shift may stimulate GSH 
biosynthesis to overcome a redox shift, thereby stimulating GSH 
biosynthesis. Our study showed that MnSOD protein expression 
was decreased when cells were exposed to 4-OHE2 for more than 
72 h, suggesting MnSOD protein expression is responsive to 
increased ROS levels caused by 4-OHE2 exposure. The decrease 
in MnSOD levels also leads to the accumulation of the superoxide 
anion (O2
•) possibly inducing further oxidative damage. 
BRCA1 and Poly (ADP-ribose) polymerase-1 (PARP-1) are 
established as DNA repair elements especially in breast tissue 
(Ginestier  et al., 2009). Previous studies have reported that 
genetic polymorphisms in these genes are closely related to the 
increased risk of breast cancer (King et al., 2003; Lane, 1992; 
Malkin et al., 1990), indicating the functional importance of these 
genes in breast cancer development. It has been reported that 
estradiol and its metabolites induce mutation of chromosome 17 
which contains the BRCA1 genes in human breast epithelial cells 
(Fernandez  et al., 2006). Deficiency of BRCA1 and PARP-1 
results in the accumulation of DNA strand breaks by impairing 
DNA damage repair, and causing defects in cell cycle 
checkpoints, centrosome amplification, and genetic instability 
(Brodie & Deng, 2001; Cantor & Andreassen, 2006; Deng & 
Wang, 2003; Venkitaraman, 2002; Zhang & Powell, 2005), 
which eventually result in tumorigenesis. Even though the effect 
was a transient, 4-OHE2  significantly decreased BRCA1 and 
PARP-1 protein expression. Since BRCA1 regulates the activity 
of nuclear factor (erythroid-derived 2)-like 2 (NFE2L2), an 
antioxidant response transcription factor, and is required for the 
repair of oxidative 8-oxoguanine lesions by transcription-coupled 
DNA repair (Bae et al., 2004), BRCA1 depletion by 4-OHE2 
possibly accelerates carcinogenesis through inhibition of DNA 
damage repair and antioxidant enzyme expression.
Besides generating ROS during redox cycling, 4-OHE2 reacts 
with DNA to form covalently bound adducts such as 4-OHE2- 
N7-Gua and 4-OHE2-N3-Ade (Belous et al., 2007). ROS-induced 
oxidized bases are predominantly repaired via the base excision 
repair process (BER). It is generally believed that the repair of 
DNA single and double stranded breaks in mammalian cells is 
initiated by PAPR-1 (de Murcia & Ménissier de Murcia, 1994; 
Plummer, 2006). Moreover, PARP-1 has a functional domain that 
includes the BRCA1 C-terminal domain (Plummer, 2006), and 
therefore PARP-1 deficiency impairs BRCA1 recruitment to the 
site of DNA damage (De Soto & Deng, 2006), which may 
facilitate cancer development. A reduction in PARP-1 protein 
expression and an increase in its activity at 48 and 96 h were 
possibly accompanied by 4-OHE2-induced ROS production. Chen 
et al. (2005) also showed that treatment with 4-OHE2 at 25 μM 
for 24 h causes PARP-1 cleavage. Depletion of both PARP-1 
and BRCA1 at 48 h can therefore cause an overload of 4-OHE2 
induced DNA damage.
Since exogenous antioxidants may regulate 4-OHE2-induced 
cellular oxidative stress, we next evaluated the effects of 
tocopherols on oxidative stress markers and DNA repair protein 
expression. In these experiments, we used tocopherols at 30 μM 
which falls within the normal range of blood level in human. 
For measurement of oxidative stress markers, 4-OHE2 and/or 
tocopherols were treated for 96 h, because our pretests indicated 
that the disturbance of antioxidatve system was induced within 
96 h. Study results indicated that in 4-OHE2 treated MCF-10A 
cells, the accumulation of intracellular ROS and depletion of 
GSH and MnSOD were significantly attenuated by γ-tocopherol. 
The antioxidant activity of tocopherols is rooted in their ability 
to donate phenolic hydrogens to lipid radicals. Because it lacks 
electron-donating methyl groups on the chromanol ring, γ
-tocopherol is somewhat less potent in donating electrons than 
α-tocopherol and thus a slightly less powerful antioxidant. 
However, the unsubstituted C-5 position of γ-tocopherol appears 
to make it as a better trap for lipophilic electrophiles such as 
reactive nitrogen oxide species (RNOSs). Jiang et al. (2002) 
showed that in vivo  γ-tocopherol supplementation, not α
-tocopherol, resulted in inhibition of protein nitration and 
ascorbate oxidation in kidney. Li et al. (1999)
  also reported that 
γ-tocopherol was more potent than α-tocopherol in enhancing 
MnSOD protein expression in arterial tissues affected by 
cardiovascular disease. Mense et al. (2009) showed that 
antioxidant vitamin C reduces the incidence of estrogen-induced 
mammary tumors and increases tumor latency through changes 
in the activities of antioxidant enzymes superoxide dismutase and 
glutathione peroxidase. The cellular functions of α-tocopherol 
that are independent of this antioxidant/radical scavenging ability 
have been well characterized. A recent report suggests that 
vitamin E isomers possess anti-cancer activity by regulating DNA 
repair gene and apoptosis via signaling pathways (Aiub et al., 
2009; Theriaut et al., 1999). Therefore, we determined the effects 
of tocopherols on DNA repair elements in 4-OHE2 induced 
oxidative stress in breast epithelial cells. We treated 4-OHE2 
and/or tocopherols for 48 h because our pretests indicated that 
4-OHE2 induced the depletion of BRCA1 and PARP-1 protein 
expression at 48 hr. Our results showed that α-tocopherol 
stimulates the up-regulated expression of DNA repair proteins, 
including BRCA1 and PARP-1. Yu et al. (2003)
  and Gu et al. 
(2008) reported that human cancer cells undergo apoptosis 
stimulated by α-tocopherol succinate in a concentration- and 
time-dependent manner by restoring PARP-1 levels. 
In conclusion, the estrogen metabolite, 4-OHE2 affects cellular 
redox status, regulates the expression of proteins closely related 
DNA repair and promotes breast cancer cell growth. As far as 190 Tocopherols suppress adverse effects of 4-hydroxyestradiol
we know, this is one of few studies to examine the involvement 
of oxidized estradiol in the impaired DNA repair. Exogenous 
α- and γ-tocopherol played a role as anti-cancer compounds by 
modulating 4-OHE2 induced oxidative stresses.
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